Before you sell to, join or invest in Sherpa RX, Inc.
MentionFox check on Sherpa RX, Inc.: only 1 source on file so far (checked 4 November 2026). Run a full check before you rely on it. mentionfox.com/c/funding/sherpa-rx-inc-form-d-25000001
Check Sherpa RX, Inc. before you sell to, join or invest Free, no sign-up: every record on file, each linked to its source.
What do you want to do about Sherpa RX, Inc.?
Based on the record MentionFox holds for this company. No flag is not a clearance.
Sherpa RX, Inc. filed a Form D with the Securities and Exchange Commission on 2025-03-21.
Sherpa RX, Inc. filed a Form D notice of an exempt securities offering with the SEC on March 21, 2025. The filing reports $325K sold. Its industry group is Other Health Care. It names Ryan Nowers (Executive Officer), Jeff McCormack (Director, Promoter), Zach Evans (Director) (SEC Form D, March 21, 2025).
Is this your company?
Sell to companies like Sherpa RX, Inc? Enter your website and see 10 with a filed reason to buy from you this month. Free.
Opens in a new tab. No signup.
New Form D on file · 2025-03-21 · the record
Pitching, partnering or investing alongside them? See who really runs and owns Sherpa RX, Inc.
Free to see. No signup.
More on the people and the money behind Sherpa RX, Inc., from the filings we hold.
Other Health Care raises by companies based in Tennessee, filed in March 2025, largest first.
Get an email when Sherpa RX, Inc. files again: a new raise, a leadership change, a layoff or an IPO filing. One email first to confirm; nothing else until you click it. At most one a day, one click to stop. Free for up to 3 companies.
We'll show it in your MentionFox inbox when Sherpa RX, Inc. raises, hires or launches. No email unless you switch it on.
Watch Sherpa RX, Inc. →Get the full cited report on Sherpa RX, Inc.
What the filing shows about Sherpa RX, Inc.
Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.
Example from a real report (our sample on Target): “The Q2 2026 earnings report, published August 19, 2026, showed adjusted EPS of $2.46 against an expected $2.33” Source: CNBC
A Full Report on Sherpa RX, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
The filing gives Sherpa RX, Inc.'s address as 1515 Russell Street, Nashville, TN 37206.
Saved here on this device in the meantime, so nothing is lost either way.
This is the company's own disclosure. A payment disclosed on a Form D is a disclosed use of proceeds, not a finding of wrongdoing.
Sherpa RX, Inc. is a registered filer with the SEC (CIK 2062019) and has filed since 2025-03-21. 1 filing is on record, the latest on 2025-03-21.
A filing shows the company exists and what it reports about itself. It is not an audit or a rating.
Sherpa RX, Inc.'s Form D of 2025-03-21 names Ryan Nowers, Jeff McCormack and Zach Evans as its officers, directors or promoters.
Its new offerings report $325K sold across 1 offering, as its own filings state.
Trailing twelve months. 863 filings in Other Health Care, totalled by week.
Ryan Nowers is named as Executive Officer on the Form D that Sherpa RX, Inc. filed with the SEC on 21 March 2025, one of 3 people that filing names.
Jeff McCormack is named as Director and Promoter on the Form D that Sherpa RX, Inc. filed with the SEC on 21 March 2025, one of 3 people that filing names.
Zach Evans is named as Director on the Form D that Sherpa RX, Inc. filed with the SEC on 21 March 2025, one of 3 people that filing names.
3 people named on the filing — 1 holding an executive role and 2 as directors only.
Named as of the 2025-03-21 filing. Titles and locations are exactly as the filing states — not independently confirmed elsewhere.
No investor is drawn from a Form D — the form states how many invested and never who.
What the filing shows about Sherpa RX, Inc.
Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.
Example from a real report (our sample on Target): “The Q2 2026 earnings report, published August 19, 2026, showed adjusted EPS of $2.46 against an expected $2.33” Source: CNBC
A Full Report on Sherpa RX, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on Sherpa RX, Inc. covers
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
Not ready to order yet? Keep this snapshot.
Sends this preview to you once; we won't add you to any list
You land back on this company when you are in.
Not ready to upgrade? Keep this one in view instead.
Watchlist Sherpa RX, Inc.You get an alert in MentionFox the next time this company shows up.
If you're behind Sherpa RX, Inc.: the weeks after a raise are watched the same way — by other investors sizing you up, and by founders checking who just got funded. FoxPlug turns your commits, deploys, and releases into that story automatically. GetFoxChat puts a guide on your own site so the people this filing just sent you don't leave after one page.
Sourced from the filing index on sec.gov.
Each opens in a new tab, filled in for Sherpa RX, Inc.. With no account yet, you sign up free and land on the result.
On these lists: Health care raises in Nashville
Share your raise. This card is drawn from the company's own Form D filing, and sharing needs no account.
https://mentionfox.com/funding/sherpa-rx-inc-form-d-25000001